| Literature DB >> 31903399 |
Jan Wilke1, Luiz Hespanhol2,3,4, Martin Behrens5.
Abstract
BACKGROUND: The fascia has been demonstrated to represent a potential force transmitter intimately connected to the underlying skeletal muscle. Sports-related soft tissue strains may therefore result in damage to both structures.Entities:
Keywords: MRI; collagen; imaging; muscle injury; return to play; ultrasound
Year: 2019 PMID: 31903399 PMCID: PMC6931154 DOI: 10.1177/2325967119888500
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Figure 1.Overview of the study flow.
Overview of the Included Studies
| Study | Analysis | Imaging | Injuries, n | Sex, n | Age, y | Setting | Delay, d |
|---|---|---|---|---|---|---|---|
| Balius[ | P | MRI | 55 | 55 M | 32 | Professional football (soccer), running, tennis, basketball | 1-7 |
| Connell[ | P | MRI/US | 42 | 42 M | NR | Professional Australian football | 2 (0-3) |
| Crema[ | R | MRI | 373 | 275 M | 25 ± 5 | Professional Australian football | 1-5 |
| Crema[ | R | MRI | 63 | 51 M, 26 F | 25 ± 5 | Olympic athletes | NR |
| Ekstrand[ | P | MRI | 233 | NR | NR | Professional football (soccer) | 1-2 |
| Koulouris[ | R | MRI/US | 179 | 154 M, 16 F | 28.2 | Athletes (diverse) | 5 (1-10) |
| Koulouris[ | R | MRI | 39 | 41 M | 24 ± 4 | Professional Australian football | 1-3 |
| Koulouris[ | R | MRI | 77 | 48 M, 11 F | 34 | Athletes (diverse) | 5 (1-12) |
| Malliaropoulos[ | P | US | 90 | NR | NR | Track & field | 2 |
| Pedret[ | P | MRI | 44 | 44 M | 32 | Professional athletes (diverse) | NR |
| Pollock[ | P | MRI | 44 | 28 M, 16 F | 24 ± 4 | Professional athletes (diverse) | <7 |
| Prakash[ | R | MRI | 114 | 89 M, 11 F | 31 | Semiprofessional athletes (diverse) | 1-14 |
| Renoux[ | R | US | 70 | 46 M, 24 F | 28 ± 6 | Professional athletes (diverse) | 1-7 |
| Waterworth[ | R | MRI | 59 | 57 M | 25 ± 3 | Professional Australian football | NR |
| Werner[ | R | MRI | 14 | 14M | 27 | Professional American football | NR |
| Yoshioka[ | NR | MRI | 7 | 5 M, 2 F | 23 | Athletes (diverse) | 1-7 |
Sample sizes were corrected for missing, incomplete, or imprecise data. F, female; M, male; MRI, magnetic resonance imaging; NR, not reported; P, prospective; R, retrospective; US, ultrasonography.
Values are expressed as mean or mean ± SD.
Delay between injury and diagnostic imaging. Values are expressed as means (if reported in the study) and ranges.
Methodological Quality of the Studies Included
| Study | Power | Aim | Sample | Outcomes | Results | Variability Estimates | Data Dredging | Objective Criteria | Accurate Measures | Random Selection/Census | Subgroups Adequate | Invited Patients Representative | Participating Patients Representative | Setting Representative | Sum Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balius[ | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0.5 | 1 | NA | 1 | 0 | 1 | 7.5/13 |
| Connell[ | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 9/14 |
| Crema[ | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 0.5 | 1 | 1 | 1 | NA | 1 | 10.5/13 |
| Crema[ | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 9/14 |
| Ekstrand[ | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 11/14 |
| Koulouris[ | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0.5 | 0 | 1 | 0 | NA | 1 | 8.5/13 |
| Koulouris[ | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | NA | 1 | 7/13 |
| Koulouris[ | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0.5 | 0 | 1 | 0 | 0 | 1 | 6.5/14 |
| Malliaropoulos[ | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 9/14 |
| Pedret[ | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0.5 | 0 | NA | 0 | 0 | 1 | 5.5/13 |
| Pollock[ | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | NA | 1 | 9/13 |
| Prakash[ | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 13/14 |
| Renoux[ | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0.5 | 1 | 1 | 1 | 1 | 1 | 12.5/14 |
| Waterworth[ | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | NA | 1 | 10/13 |
| Werner[ | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0.5 | 0 | 1 | 1 | 0 | 1 | 9.5/14 |
| Yoshioka[ | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 5/14 |
1, criterion met (1 point awarded); 0, criterion not met (0 points awarded); NA, not applicable (not included in composite score).
Prevalence of Lesions by Type in the Included Studies
| Study | Myofascial Lesion | Myotendinous Lesion | Muscular Lesion |
|---|---|---|---|
| Balius[ | S, 24/55 | S, 31/55 | — |
| Connell[ | HS, 15/42 | HS, 25/42 | — |
| Crema[ | BF, 56/239; SM, 2/48; ST, 8/86 | BF, 131/239; SM, 33/48; ST, 17/86 | BF, 52/239; SM, 13/48; ST, 61/86 |
| Crema[ | Diverse, 20/63 | Diverse, 43/63 | — |
| Ekstrand[ | HS, 69/233 | HS, 142/233 | HS, 22/233 |
| Koulouris[ | BF, 43/124; ST, 3/9; SM, NR | BF, 76/124; ST, 5/9; SM, 17/21 | BF, 5/124; ST, 1/9; SM, NR |
| Koulouris[ | HS, 15/39 | HS, 24/39 | — |
| Koulouris[ | G, 0/39; S, 17/34 | G, 39/39; S, 17/34; TP, 3/3; FHL, 1/1 | — |
| Malliaropoulos[ | HS, 5/90 | HS, 85/90 | — |
| Pedret[ | S, 12/44 | S, 32/44 | — |
| Pollock[ | HS, 7/44 | HS, 37/44 | — |
| Prakash[ | S, 36/79; G, 20/35 | S, 43/79; G, 15/35 | — |
| Renoux[ |
|
|
|
| Waterworth[ | S, 5/34 | S, 29/34 | S, 0/34 |
| Werner[ | CM, 12/14 | — | CM, 2/14 |
| Yoshioka[ | BF/ST, 5/5; RF 0/1; RF/VL, 1/1 | — | BF/ST, 1/5; RF 1/1; RF/VL, 0/1 |
| Total | 375/1348 | 845/1362 | 158/794 |
Values are expressed as numbers of lesions. Dashes indicate not determined or not investigated. BF, biceps femoris; CM, calf muscles; FHL, flexor hallucis longus; G, gastrocnemius; HS, hamstrings; NR, not reported; RF, rectus femoris; S, soleus; SM, semimembranosus; ST, semitendinosus; TP, tibialis posterior; VL, vastus lateralis.
No clear differentiation between muscular, myofascial, and tendinous injuries.
Figure 2.Forest plot displaying the individual and pooled prevalences (random effects [RE] meta-analysis) of myofascial damage in muscle strain injury. Values displayed are mean proportions and 95% CIs.
Figure 3.Forest plot displaying the individual and pooled prevalences (random effects [RE] meta-analysis) of myotendinous damage in muscle strain injury. Values displayed are mean proportions and 95% CIs.
Figure 4.Forest plot displaying the individual and pooled prevalences (random effects [RE] meta-analysis) of isolated muscle damage in muscle strain injury. Values displayed are mean proportions and 95% CIs.
Associations Between Fascial Lesions and Aspects of Return to Play
| Study | Outcome | Finding |
|---|---|---|
| Connell[ | RTP time and type of CT involvement | No significant difference between RTP time in myofascial (27.1 d) vs myotendinous (25.9 d) lesions. No comparison was made with muscular lesions. |
| Ekstrand[ | RTP time and CT involvement | No significant differences between RTP time in myotendinous (20 ± 15 d; 95% CI, 18-23 d), myofascial (19 ± 15 d; 95% CI, 15-23 d), and muscular (20 ± 10 d; 95% CI, 16-25 d) lesions. |
| Pedret[ | RTP time and type of CT involvement | No significant difference between RTP time in myofascial (35 ± 22 d) vs myotendinous (27 ± 18 d) lesions. No comparison with muscular lesions. |
| Pollock34 | RTP time and type of CT involvement | No significant difference between RTP time in myofascial vs
myotendinous lesions ( |
| Prakash[ | RTP time and CT involvement | Significantly higher RTP time in injuries with CT involvement (25 ± 10 to 48 ± 16 d) vs no CT involvement (17 ± 9 d). |
| Renoux[ | RTP time and CT involvement | Higher RTP time in injuries with CT involvement (7.6 ± 2.9 wk; 95% CI, 6.3-8.9 wk) vs without CT involvement (3.9 ± 1.4 wk; 95% CI, 3.5-4.3 wk). |
| Werner[ | RTP time and size of fascial lesion | Players with higher RTP time (>2 wk) exhibit larger (27 ± 18 mm) fascial lesions than players with shorter (≤2 wk) RTP time (8 ± 6 mm). |
CT, connective tissue; RTP, return to play.
Pollock et al[34] found comparable values and no systematic difference between myofascial and myotendinous lesions.